{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:57:34Z","timestamp":1782867454675,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1136\/ard.62.11.1106","type":"journal-article","created":{"date-parts":[[2003,10,28]],"date-time":"2003-10-28T18:51:57Z","timestamp":1067367117000},"page":"1106-1111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Anticardiolipin, anti-\u03b22-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease"],"prefix":"10.1016","volume":"62","author":[{"given":"S","family":"Loizou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Wypkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Asherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.62.11.1106_bib1","doi-asserted-by":"crossref","unstructured":"Asherson RA, Cervera R, Piette JC, Shoenfeld Y. The antiphospholipid syndrome: History, definition, classification and differential diagnosis. In: Asherson RA Cervera R Piette JC Shoenfeld Y, eds. The antiphospholipid syndrome. Boca Raton, Florida, USA: CRC press, 1996:3\u201312.","DOI":"10.1201\/9781351077125-1"},{"key":"10.1136\/ard.62.11.1106_bib2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/art.1780390903","article-title":"Immunology of the antiphospholipid antibody syndrome","volume":"39","author":"Roubey","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.62.11.1106_bib3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.4049\/jimmunol.154.2.954","article-title":"\u2018Anti-cardiolipin\u2019 autoantibodies recognize \u03b2 2 -glycoprotein I in the absence of phospholipid. Importance of antigen density and bivalent binding","volume":"154","author":"Roubey RA","year":"1995","journal-title":"J Immunol"},{"key":"10.1136\/ard.62.11.1106_bib4","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1055\/s-0038-1649891","article-title":"Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants","volume":"74","author":"Arvieux","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.62.11.1106_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/blood.V86.2.617.bloodjournal862617","article-title":"Kaolin clotting time and dilute Russell\u2019s viper venom time distinguish between prothrombin- and \u03b2 2 -glycoprotein I-dependent antiphospholipid antibodies","volume":"86","author":"Galli","year":"1995","journal-title":"Blood"},{"key":"10.1136\/ard.62.11.1106_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF02231680","article-title":"Autoantibodies in leprosy sera","volume":"15","author":"Guedes Barbarosa","year":"1996","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.62.11.1106_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1055\/s-0038-1656067","article-title":"Autoantibodies to phospholipids and to the coagulation proteins in AIDS","volume":"77","author":"Abuaf","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.62.11.1106_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(99)00059-6","article-title":"Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome","volume":"96","author":"de Laranaga","year":"1999","journal-title":"Thromb Res"},{"key":"10.1136\/ard.62.11.1106_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/jaut.2000.0401","article-title":"Which are the best biological markers of the antiphospholipid syndrome","volume":"15","author":"Carreras","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.62.11.1106_bib10","doi-asserted-by":"crossref","unstructured":"Zandman-Goddard G, Blank M, Shoenfeld Y. Antiphospholipid antibodies and infections-drugs. In: Asherson RA Cervera R Piette JC Shoenfeld Y, eds. The antiphospholipid syndrome II. Amsterdam: Elsevier Science, 2002:343\u201360.","DOI":"10.1016\/B978-044450987-1\/50033-4"},{"key":"10.1136\/ard.62.11.1106_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/jaut.1999.0324","article-title":"Antiphospholipid antibodies in HIV infection and SLE with and without antiphospholipid syndrome; comparisons of phospholipid specificity, avidity and reactivity with \u03b22-GPI","volume":"13","author":"Petrovas","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.62.11.1106_bib12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.60.5.500","article-title":"Cofactor dependence and isotype distribution of anticardiolipin antibodies in viral infections","volume":"60","author":"Gugliemone","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.62.11.1106_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1055\/s-0038-1650354","article-title":"Reactivity to beta2glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis","volume":"75","author":"Forastiero","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.62.11.1106_bib14","first-page":"492","article-title":"Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations","volume":"18","author":"Elbeialy","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.62.11.1106_bib15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1191\/096120300678828712","article-title":"High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity","volume":"9","author":"de Laranaga","year":"2000","journal-title":"Lupus"},{"key":"10.1136\/ard.62.11.1106_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2141.1998.00722.x","article-title":"Prevalence and significance of anticardiolipin, anti-\u03b22 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C","volume":"101","author":"Leroy","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1136\/ard.62.11.1106_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s005350050345","article-title":"High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications","volume":"35","author":"Harada","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1136\/ard.62.11.1106_bib18","first-page":"660","article-title":"Are anticardiolipin antibodies responsible for some of the complications of severe acute Plasmodium facliparum malaria?","volume":"83","author":"Soni","year":"1993","journal-title":"S Afr Med J"},{"key":"10.1136\/ard.62.11.1106_bib19","doi-asserted-by":"crossref","unstructured":"Loizou SA, Walport MJ, Davies KA. The antiphospholipid syndrome in infectious diseases. In: Asherson RA Cervera R Piette JC Shoenfeld Y, eds. The antiphospholipid syndrome. Boca Raton, Florida, USA: CRC Press, 1996:267\u201384.","DOI":"10.1201\/9781351077125-23"},{"key":"10.1136\/ard.62.11.1106_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/clin.1996.0089","article-title":"Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus","volume":"80","author":"Puurunen","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1136\/ard.62.11.1106_bib21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1055\/s-0037-1614164","article-title":"Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests","volume":"84","author":"Galli","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1136\/ard.62.11.1106_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00124743-200210000-00004","article-title":"Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome","volume":"8","author":"Salcido-Ochoa","year":"2002","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/ard.62.11.1106_bib24","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1136\/ard.62.5.388","article-title":"Infections, Antiphospholipid antibodies and syndromes","volume":"62","author":"Asherson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.62.11.1106_bib25","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.11.1106_bib26","first-page":"12","article-title":"The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome\u2013molecular mimicry?","volume":"27","author":"Asherson","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.62.11.1106_bib27","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0889-857X(05)70219-2","article-title":"Origin of antiphospholipid antibodies","volume":"27","author":"Gharavi","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.62.11.1106_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI0212337","article-title":"Bacterial induction of autoantibodies to \u03b22-glycoprotein-I accounts for the infectious aetiology of antiphospholipid syndrome","volume":"109","author":"Blank","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.62.11.1106_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.62.11.1106_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/096120339400300615","article-title":"Anticardiolipin antibodies in infections are heterogeneous in their dependency on \u03b22-glycoprotein I: analysis of anticardiolipin antibodies in leprosy","volume":"3","author":"Hojnik","year":"1994","journal-title":"Lupus"},{"key":"10.1136\/ard.62.11.1106_bib31","first-page":"376","article-title":"\u03b22-glycoprotein I dependence of anticardiolipin antibodies in multibacillary leprosy patients","volume":"69","author":"Fiallo","year":"1998","journal-title":"Lepr Rev"},{"key":"10.1136\/ard.62.11.1106_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1098-2825(1999)13:2<59::AID-JCLA3>3.0.CO;2-Q","article-title":"Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship to \u03b22-glycoprotein I","volume":"13","author":"Gonzalez","year":"1999","journal-title":"J Clin Lab Anal"},{"key":"10.1136\/ard.62.11.1106_bib33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2249.1997.4601357.x","article-title":"Antibodies to \u03b22-glycoprotein I \u2013 a specific marker for antiphospholipid syndrome","volume":"109","author":"Guerin","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.62.11.1106_bib34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/096120339900800618","article-title":"Transitory anti-\u03b22-glycoprotein I antibodies in infections","volume":"8","author":"Guerin","year":"1999","journal-title":"Lupus"},{"key":"10.1136\/ard.62.11.1106_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.1996.03530270050031","article-title":"The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention","volume":"275","author":"Hu","year":"1996","journal-title":"JAMA"},{"key":"10.1136\/ard.62.11.1106_bib36","first-page":"397","article-title":"Antiphospholipid antibodies in syphilis","volume":"23","author":"Santiago","year":"1990","journal-title":"Braz J Med Biol Res"},{"key":"10.1136\/ard.62.11.1106_bib37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2249.1994.tb06528.x","article-title":"High levels of anti-phospholipid antibodies in uncomplicated and severe Plasmodium falciparum and in P. vivax malaria","volume":"95","author":"Facer","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.62.11.1106_bib23","first-page":"1477","article-title":"Precipitin reaction bei syphilis","volume":"44","author":"Michaelis","year":"1907","journal-title":"Berl Klin Wochenschr"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724087879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724087879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.62.11.1106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:32:48Z","timestamp":1737243168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724087879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0003496724087879"],"URL":"https:\/\/doi.org\/10.1136\/ard.62.11.1106","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticardiolipin, anti-\u03b22-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.62.11.1106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Copyright 2003 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}